HISTOLOGICAL OUTCOMES AND THE IMMUNE LANDSCAPE IN ULCERATIVE COLITIS PATIENTS TREATED WITH TOFACITINIB

Sara van Gennep  1     Ivan Fung  1     Djuna C de Jong  1     Rishand K. Ramkisoen  1     Esmé Clasquin  1     Jitteke de Jong  1     Leonie CS de Vries  1     Wouter J. de Jonge  1     Krisztina B. Gecse  1     Mark Lowenberg  1     John C. Woolcott  2     Aart Mookhoek  3     Geert R. D'Haens  1    
1 Amsterdam UMC, Amsterdam, Netherlands
2 Pfizer Inc., Collegeville, United States
3 Bern University Hospital, Bern, Switzerland

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing